Cancer Research Technology
Log in Register
Menu

Anti-HIV Designer Antigen (DAG19) polyclonal antibody
NEW

Invented by Dr Tuck-Weng Kok at The University of Adelaide

Info

Catalogue Number 154855
Applications ELISA IF WB
Antigen/Gene or Protein Targets DAG19
Synonyms human immunodeficiency virus designer antigen
Reactivity Human, Guinea Pig and Rat
Relevance DAGs ‘designer antigens’ carry epitopes that can lead to the elicitation of broadly neutralizing antibodies (bNAbs). BNAbs are a consistent protective immune correlate in human immunodeficiency virus (HIV) patients as well as in passive immunotherapy studies. The inability to elicit bNAbs is the core reason underlining the repeated failures in traditional HIV vaccine research. The DAG16, 19 and 23 have been used to produce monoclonal antibodies specific to novel epitopes on HIV prefusion intermediates.
Host Guinea Pig
Immunogen HIV DAG 19
Research Area Immunology, Virology

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Kok et al. 2014. Clin Transl Immunology. 3(9):e24. PMID: 25505973.


Add a reference

References: 1 entry

Kok et al. 2014. Clin Transl Immunology. 3(9):e24. PMID: 25505973.


Add a reference